drugset / Trial / NCT01048580
Study of Perifosine + Capecitabine for Colon Cancer Patients
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase I study of Perifosine + Capecitabine for patients with advanced colon cancer.
Timeline
- Start
- 2009-10
- Primary completion
- 2011-05
- Completion
- 2011-10
Publications
- Results Journal of Oncology, 2010 ASCO Annual Meeting Abstracts. Vol. 28, No. 15_suppl (May 20Supplement), 2010:e14086
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 1000 mg/m2 | Oral |
| Subject | Perifosine | Small molecule | 50 mg | Oral |